ASCO Ovarian Cancer News:

Drug keeps ovarian cancer in check, study finds
In a study of 1,873 women with untreated ovarian cancer, Avastin extended progression-free survival by 39% compared with standard chemotherapy alone.

Read this article by Thomas H. Maugh II of the Los Angeles Times on the Chicago Tribune’s Website (not quite sure why) by going to:
Avastin Extends Progression-Free Survival.

Feel good and keep smiling! Pat

2 thoughts on “Avastin Extends Progression-Free Survival By 39% In Women With Previously Untreated Ovarian Cancer

  1. Thanks, Rebecca! How fortunate she is to still be cancer free almost seven years after her surgery and chemotherapy. Lots of Taxol for six months… Yuck! Pat

Leave a Reply